日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oxidative hypoxia drives TGF-β1-induced fibrosis under normoxia

在常氧条件下,氧化性缺氧驱动TGF-β1诱导的纤维化。

Choi, JinHyuk; Kim, Youngmee; Abeysiriwardhana, Hiruni Nilshi Indeevarie; Malla, Ayusha; Kim, Jae-Won; Anandappa, Joshua Miguel; Liang, Zhuoning; Seo, Suyoung; Liu, Kwang-Hyeon; Rhee, Sangkee; Nahm, Sang-Soep; Kim, Eui Tae; Lim, Yoongho; Cho, Moonjae

Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study

英国TRACC B部分研究:结合基因组和甲基化信号的无组织液体活检用于早期结直肠癌患者微小残留病灶检测

Slater, Susanna; Bryant, Annette; Aresu, Maria; Begum, Ruwaida; Chen, Hsiang-Chi; Peckitt, Clare; Lazaro-Alcausi, Retchel; Carter, Paul; Anandappa, Gayathri; Khakoo, Shelize; Melcher, Lucinda; Potter, Vanessa; Marti, Francisca M; Huang, Joesph; Branagan, Graham; George, Nicol; Abulafi, Muti; Duff, Sarah; Raja, Ashraf; Gupta, Ashish; West, Nicholas; Bucheit, Leslie; Rich, Thereasa; Chau, Ian; Cunningham, David; Starling, Naureen

Longitudinal Intravascular Antibody Labeling Identified Regulatory T Cell Recruitment as a Therapeutic Target in a Mouse Model of Lung Cancer.

纵向血管内抗体标记法确定调节性 T 细胞募集是肺癌小鼠模型中的治疗靶点

Shanahan Sean-Luc, Kunder Nikesh, Inaku Charles, Hagan Natalie B, Gibbons Grace, Mathey-Andrews Nicolas, Anandappa Gayathri, Soares Shawn, Pauken Kristen E, Jacks Tyler, Schenkel Jason M

Anandappa A, Curran E. Challenges to successful outcomes in AYAs with ALL and potential solutions. Hematology Am Soc Hematol Educ Program. 2023;2023(1):587-592

Anandappa A, Curran E. ALL青少年及青年患者成功治疗面临的挑战及潜在解决方案。血液学美国血液学会教育项目。2023;2023(1):587-592

Anandappa, A; Curran, E

New insights into macrophage polarization and its prognostic role in patients with colorectal cancer liver metastasis

巨噬细胞极化及其在结直肠癌肝转移患者预后中的作用的新见解

Khanduri, Isha; Maki, Harufumi; Verma, Anuj; Katkhuda, Riham; Anandappa, Gayathri; Pandurengan, Renganayaki; Zhang, Shanyu; Mejia, Alicia; Tong, Zhimin; Solis Soto, Luisa M; Jadhav, Akshaya; Wistuba, Ignacio I; Menter, David; Kopetz, Scott; Parra, Edwin R; Vauthey, Jean-Nicolas; Maru, Dipen M

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

慢性淋巴细胞白血病向里氏综合征转变的演变史

Erin M Parry # ,Ignaty Leshchiner # ,Romain Guièze # ,Connor Johnson ,Eugen Tausch ,Sameer A Parikh ,Camilla Lemvigh ,Julien Broséus ,Sébastien Hergalant ,Conor Messer ,Filippo Utro ,Chaya Levovitz ,Kahn Rhrissorrakrai ,Liang Li ,Daniel Rosebrock ,Shanye Yin ,Stephanie Deng ,Kara Slowik ,Raquel Jacobs ,Teddy Huang ,Shuqiang Li ,Geoff Fell ,Robert Redd ,Ziao Lin ,Binyamin A Knisbacher ,Dimitri Livitz ,Christof Schneider ,Neil Ruthen ,Liudmila Elagina ,Amaro Taylor-Weiner ,Bria Persaud ,Aina Martinez ,Stacey M Fernandes ,Noelia Purroy ,Annabelle J Anandappa ,Jialin Ma ,Julian Hess ,Laura Z Rassenti ,Thomas J Kipps ,Nitin Jain ,William Wierda ,Florence Cymbalista ,Pierre Feugier ,Neil E Kay ,Kenneth J Livak ,Brian P Danysh ,Chip Stewart ,Donna Neuberg ,Matthew S Davids ,Jennifer R Brown ,Laxmi Parida ,Stephan Stilgenbauer ,Gad Getz ,Catherine J Wu

ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome

ZNF683 标记一种 CD8+ T 细胞群,该细胞群与 Richter 综合征患者接受抗 PD-1 治疗后的抗肿瘤免疫相关。

Erin M Parry ,Camilla K Lemvigh ,Stephanie Deng ,Nathan Dangle ,Neil Ruthen ,Binyamin A Knisbacher ,Julien Broséus ,Sébastien Hergalant ,Romain Guièze ,Shuqiang Li ,Wandi Zhang ,Connor Johnson ,Jaclyn M Long ,Shanye Yin ,Lillian Werner ,Annabelle Anandappa ,Noelia Purroy ,Satyen Gohil ,Giacomo Oliveira ,Pavan Bachireddy ,Sachet A Shukla ,Teddy Huang ,Joseph D Khoury ,Beenu Thakral ,Michael Dickinson ,Constantine Tam ,Kenneth J Livak ,Gad Getz ,Donna Neuberg ,Pierre Feugier ,Peter Kharchenko ,William Wierda ,Lars Rønn Olsen ,Nitin Jain ,Catherine J Wu

Harnessing the therapeutic vulnerability of MMR heterogeneity in colorectal cancer

利用结直肠癌中MMR异质性的治疗脆弱性

Anandappa, Gayathri; Overman, Michael J

ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)

ctDNA指导的辅助化疗与根治性手术后高危II期或III期结直肠癌患者的标准辅助化疗:一项多中心、前瞻性、随机对照试验(TRACC C部分)

Slater, Susanna; Bryant, Annette; Chen, Hsiang-Chi; Begum, Ruwaida; Rana, Isma; Aresu, Maria; Peckitt, Clare; Zhitkov, Oleg; Lazaro-Alcausi, Retchel; Borja, Victoria; Powell, Rachel; Lowery, David; Hubank, Michael; Rich, Thereasa; Anandappa, Gayathri; Chau, Ian; Starling, Naureen; Cunningham, David

Challenges to successful outcomes in AYAs with ALL and potential solutions

青少年和青年急性淋巴细胞白血病(ALL)患者成功治疗面临的挑战及潜在解决方案

Anandappa, Annabelle; Curran, Emily